After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Exercise
Reported value range
Not reported

Megna Michael R Chief Accounting Officer

Transaction date Sep 1, 2026
Public filing date Sep 3, 2026
Filing lag Filed 2 days later

KNSA daily price context

Close on/before transaction
$79.28 Sep 1, 2026
First close after public filing
$77.91 Sep 4, 2026
30-day return after filing
-2.05% Through Oct 5, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Class A Ordinary Share
Quantity / price
2,362 shares
SEC ownership
Direct
Transaction code
M
Form
4
Filing identifier
0001464583-26-000008
Filing cohort

Transactions in this filing

Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$817.22K
Buys / sales
0 / 1
Transactions reported in the same official filing
Issuer Transaction Traded Value
Kiniksa Pharmaceuticals International, Plc KNSA Sale Sep 3, 2026 $369.38K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 Not reported
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 Not reported
Kiniksa Pharmaceuticals International, Plc KNSA Disposition Sep 1, 2026 $438.5K
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 Not reported
Kiniksa Pharmaceuticals International, Plc KNSA Current Exercise Sep 1, 2026 Not reported
Kiniksa Pharmaceuticals International, Plc KNSA Award Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Award Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Exercise Sep 1, 2026 $0
Kiniksa Pharmaceuticals International, Plc KNSA Award Jul 15, 2026 $9.35K